Objective Comorbidities between psychiatric diseases and use of traditional substances of abuse are common. Nevertheless, there are few data regarding the use of novel psychoactive substances (NPS) among psychiatric patients. Aim of this multicentre survey is to investigate the consumption of a number of psychoactive substances in a young psychiatric sample.
The European Commission (2011) , in response to recent developments in the European drug market, has investigated the experiences and attitudes of adolescents and young adults towards NPS. The sample included over 12,000 young people (aged 15-24 years), randomly selected across the 27 EU Member States. Overall, 5% of the participants reported having used NPS: Ireland (16%), Poland (9%), Latvia (8.8%), and United Kingdom (8%) were at the top of the ranking list, while Italy (0.8%), Finland (1%), and Greece (1.6%) were at the bottom (European Commission, 2011) . A recent study on a population of 3,011 subjects aged 16-24 highlighted a quick increase in NPS use figures in Italy, as in 2015 the rate stands at 4.7% (Martinotti, Lupi, Carlucci, et al., 2015a) .
These substances are often synthesized in underground laboratories, simply modifying the molecular structure of controlled drugs, hence raising further concerns in terms of the presence of contaminating agents (UNODC, 2014a) . NPS are raising a growing number of sanitary concerns, but so far, their clinical effects are still poorly known, and may vary considerably between substances (Anderson, Morrell, & Marchevsky, 2015) . A consistent body of clinical evidence currently demonstrates the potential acute and chronic health harms associated with the use of NPS ; however, these substances are still often unknown to health professionals, mainly because of the lack of evidence-based sources of information (Simonato, Corazza, Santonastaso et al., 2013) .
With regard to the most frequently observed clinical features related to NPS consumption, anxiety, dysphoria, increased aggression, mood fluctuations, and perceptual or thought disturbances are to be mentioned (Anderson et al., 2015) . Moreover, Papanti, Schifano, Botteon et al. (2013) coined the term "Spiceophrenia," to define some peculiar psychopathological characteristics of spice-induced psychosis (e.g., paranoid thoughts/combativeness/irritability); according to their assumptions, it is possible to hypothesize that the use of synthetic cannabinoids may "trigger" the occurrence or the relapse of psychosis in psychosis vulnerable individuals or in patients with a prodromal psychotic syndrome (Papanti et al., 2013) . Other studies showed that synthetic cathinones appear to be peculiarly involved in the development of both self-and other-oriented aggression; users of cathinones tend in fact to manifest violent behaviours, including suicide (Marinetti & Antonides, 2013) .
The purpose of this multicentre survey was to investigate the diffusion of NPS consumption in a young Italian psychiatric sample, and to correlate it with the psychiatric diagnoses. Secondary aims were represented by the assessment of different associated behaviours, such as the use of caffeine, tobacco, and drinking habits.
| METHODS

| Sample
A questionnaire was administered to a sample of 671 psychiatric patients (48.5% men; 51.5% women), aged 18-26 (mean age 22.24, SD 2.87). The sample was composed of patients consecutively admitted in 10 recruiting psychiatric inpatient units, located in the north, centre, and south of Italy, from December 2013 to September 2015.
The centres involved in the study were the G d'Annunzio University of Chieti, the University of Turin, the University of Bologna, the "Fatebenefratelli" General Hospital of Milan, the University of Perugia, "Tor Vergata" University of Rome, the University of Catanzaro, the University of Messina, the University of Catania, and the University of Cagliari. The aim of this wide selection was to obtain a sample, which could be representative of the whole Italian scenery, involving some of the most populated areas of the country. The study received the approval of the local ethics committee and of the Institutional Review Board. All subjects with a Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition clinical diagnosis were invited to participate. Exclusion criteria were failure to obtain informed written consent and a lifetime diagnosis of substance use disorder.
Data collection was carried out in an anonymous way; all participants received a detailed explanation of the design of the study and a written informed consent was obtained from all respondents, according to the Declaration of Helsinki.
| Measure
A questionnaire investigating NPS use and binge drinking, already used for previous studies, was adopted (Martinotti et al., 2014) . The test was self-administered and consisted of 31 items, which investigated socioeconomic characteristics (age, gender, residence, job status, and living status), alcohol use, legal stimulants use (tobacco and caffeine), "classic" substances use (e.g., cannabis, cocaine, and opiates), and use of NPS. The NPS included in the questionnaire were synthetic cannabinoids (spices and spice drugs), synthetic cathinones (e.g., mephedrone), piperazines, tryptamines, phenethylamines (Nbomefly-solaris), ayahuasca, Salvia divinorum, kratom, γ-hydroxybutyric acid, methoxetamine (Special M), and desomorphine (krokodil). Popular street names were used along with chemical ones.
| Statistical analysis
The SPSS version 22 was used for the analyses. In all statistical analyses, a two-sided significance level of 5% was used. To identify predictors correlated with NPS use and binge drinking, univariate logistic regression analyses were performed for the demographic and clinical features of the sample. For the features with a p value of less than .05 in the univariate logistic regression analyses, a multivariate logistic regression analysis was performed. The predictors with a p value of .05 or less in the multivariate analysis were identified to be significantly correlated with NPS and binge drinking.
| RESULTS
The psychiatric diagnoses were distributed as follows: 21% (N = 141) schizophrenia and other psychotic disorders; 16.1% (N = 108) depressive disorders; 11.3% (N = 76) bipolar disorders; 20.4% (N = 137) anxiety disorders; 19.7% (N = 132) personality disorders; 4.3% (N = 29) obsessive-compulsive disorder; 5.8% (N = 39) eating disorders; 1.3% (N = 9) other disorders (see Table 1 for details regarding socio-demographic characteristics of the sample).
With regard to alcohol consumption, 70.6% (N = 474) of the sample declared alcohol use, and 47.7% (N = 320) reported to have drunk alcoholic beverages until losing control at least once (binge drinking: this term defines the consumption of five or more drinks in a row for men and four or more drinks for women; Wechsler & Nelson, 2001 ). 52,8% (N = 287) of the sample smoked tobacco. Among the "classic" illicit drugs, the most used were cannabis, with a prevalence of 31.4% (N = 211), and cocaine, with a prevalence of 10.7% (N = 72).
About 8.2% (N = 55) of the sample reported to have used NPS at least once, while 2.2% (N = 15) has assumed NPS in the last 3 months. The most commonly consumed NPS were synthetic cannabinoids (spices; 4.5%, N = 30). The three psychiatric diagnoses most frequently associated with NPS consumption were bipolar disorder (23.1% N = 15), personality disorders (11.8% N = 13), and schizophrenia and related disorders (11.6% N = 13) (see Figure 1 for details).
In univariate regression analysis, bipolar disorder emerged as significantly associated with NPS consumption (p < .001). However, in the multivariate model, no psychiatric diagnosis was directly associated to NPS consumption, while predictors were use of other illicit substances (cannabis and cocaine), binge drinking behaviours, coffee consumption, and living status (living with a partner) (see Table 2 for details).
In the univariate analysis, bipolar disorder was positively associated with binge drinking, while obsessive-compulsive disorder showed an inverse association. In the multivariate analysis, factors associated with binge drinking were male gender, being unemployed, smoking habit, coffee consumption, use of cocaine and cannabis, and bipolar disorder diagnosis (see Table 3 for details).
| DISCUSSION
To of our knowledge, this study investigates the use of NPS in psychiatric patients within the largest sample ever collected. Our results suggest a prevalence of NPS use among psychiatric patients that appears to be higher than in general population (UNODC, 2014b) . This could represent an important finding, because a deleterious effect of NPS on psychopathological domains is often advocated. Several NPS have been associated, based on their mechanism of action, to an increased risk of psychosis: mephedrone and phenethylamines through an increase of dopamine levels (Brisch, Saniotis, Wolf et al., 2014) , synthetic cannabinoids via the activation of CB1 receptor (Hajos, Hoffmann, & Kocsis, 2008) , methoxetamine through agonism on 5-HT2A receptors and antagonism on NMDA receptor (Morris & Wallach, 2014) , Salvia divinorum via k-opioid receptor activation (Ranganathan, On the other hand, the use of NPS may be considered as an attempt to relieve the distressful emotional and cognitive experiences due to the psychiatric disorder. Indeed, the self-medication with drugs of abuse among psychiatric patients, as postulated for the first time by
Khantzian, had a wide resonance in the last decades (Khantzian, 1997 ).
This hypothesis states that individuals with psychiatric disorders may use substances for relieving their symptoms, thanks to the unique pharmacological properties of the substance, whereby the presence of specific symptoms would lead to the search of a specific substance.
Although theorized for the traditional drugs, this hypothesis seems particularly attractive for NPS as well, given the frequent search and the easy supply of these substances on the Internet market (Orsolini, Francesconi, Papanti et al., 2015) and the presence of online communities of recreational drug users that report detailed experiences with groups of substances (e-psychonauts; Deluca, Davey, Corazza et al., 2012 and euphoric substances (e.g., piperazines). Note. CI = confidence interval; NPS = novel psychoactive substances; OCD = obsessive-compulsive disorder; OR = odds ratio. Note. CI = confidence interval; OCD = obsessive-compulsive disorder; OR = odds ratio.
Moreover, attempts towards potential therapeutic applications of NPS, moving from their pharmacological properties, have been recently made (Davidson & Schifano, 2016) . However, at present, these hypotheses are merely speculative and they are not specifically addressed in this paper.
In our study, a generic proneness toward the use of recreational substances was the best predictor of use of NPS, as suggested by another recent paper on the topic (Stanley, Mogford, Lawrence, & Lawrie, 2016) . Therefore, especially in this subpopulation of patients, questions specifically addressed to NPS consumption may represent a good screening strategy in clinical practice. Interestingly, coffee consumption resulted as an independent risk factor for NPS use, an association never described so far in both clinical and nonclinical settings.
Moreover, a more independent living status, without a direct parental control, has been found to be another risk factor for NPS use.
On the contrary, specific psychiatric diagnoses were not directly associated with an increased risk of NPS consumption. This finding could be due to an insufficient sample size or to the heterogeneity of NPS, so an analysis based on single NPS classes (e.g., synthetic canna- Psychoma, may closely resemble psychotic experiences (Martinotti, Di Nicola, Quattrone et al., 2015b) . However, our data do not confirm this hypothesis. In our sample, the use of NPS resulted to be uncommon among patients affected by schizophrenia and other psychosis.
A possible hypothesis is that NPS may induce transient episodes, but not usually a full-blown psychosis. Differently, a casual relation between bipolar disorder and NPS may be hypothesized. NPS use is probably able to worsen a preexisting scenery or a subthreshold disorder, determining a higher severity of symptoms and a higher frequency of episode relapsing. Moreover, the major use of NPS in bipolar patients could be related with the impulsivity and novelty seeking behaviors often observed in the maniac or hipomaniac states.
The positive association between bipolar disorder and binge drinking confirms the literature data on the association of bipolar disorder with alcohol use and misuse (Balanzá-Martínez, Crespo-Facorro, González-Pinto et al., 2015; Martinotti, Carli, Tedeschi et al., 2009 ).
Among the main limitations of this preliminary observational study, it must be underlined the use of self-reported data, without the support of laboratory analysis to rule out false negatives and false positives. Another main limitation is the lack of data regarding the temporal relationships between the emerging of psychiatric symptomatology and the use of recreational drugs, as well as regarding the reasons that had led to substance use. Moreover, we considered only the main psychiatric diagnosis, without investigate potential comorbidities.
Finally, we studied the group of NPS as a whole, despite the heterogeneity among the single substances. However, given the wide diffusion of polyabuse behaviours, we decided not to differentiate the sample by use of different NPS. Despite these limitations and the need of other studies with a higher casuistry, this study provides significant findings in a field still underinvestigated and of great relevance for 21st-century psychiatry.
| CONCLUSION
In conclusion, our research highlighted that the use of NPS in a sample of psychiatric patients is highly represented and needs to be regularly investigated, demonstrating that a deep knowledge of these substances is now compulsory for psychiatrists. Moreover, we demonstrated that bipolar disorder, more than schizophrenia and other psychosis, is the main psychiatric diagnostic framework within which the use of NPS is reported. Further studies and preventive strategies developments are therefore needed to better address this issue.
